2-Cyclohexylphenyl 3-pyridinecarboxylate | 76959-47-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚酯
• 英文名称: 2-Cyclohexylphenyl 3-pyridinecarboxylate
• 英文别名: (2-cyclohexylphenyl) pyridine-3-carboxylate
• CAS: 76959-47-2
• 化学式: C₁₈H₁₉NO₂
• 分子量: 281.3
• InChiKey: QCGOZOLLKOPOTM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-Cyclohexylphenyl 3-pyridinecarboxylate 、 间氯过氧苯甲酸 生成 (2-Cyclohexylphenyl) 1-oxidopyridin-1-ium-3-carboxylate
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
  申请人：——

  公开号：US20040067918A1

  公开（公告）日：2004-04-08

  Novel methods and combinations for the treatment and/or prophylaxis of a pathologic condition in a subject, wherein the methods comprise the administration of one or more aldosterone receptor antagonists and one or more, nicotinic acid derivatives and the combinations comprise one or more of said aldosterone receptor antagonists and one or more of said nicotinic acid derivatives.

  用于治疗和/或预防受试者病理状况的新型方法和组合，其中所述方法包括施用一种或多种醛固酮受体拮抗剂和一种或多种烟酸衍生物，所述组合包括一种或多种所述醛固酮受体拮抗剂和一种或多种所述烟酸衍生物。
• ——
  作者：

  DOI：——

  日期：——
• COMBINATION OF AN ALDOSTERONE RECEPTOR ANTAGONIST AND NICOTINIC ACID OR A NICOTINIC ACID DERIVATIVE
  申请人：Pharmacia Corporation

  公开号：EP1485104A1

  公开（公告）日：2004-12-15
• ENHANCED METHOD OF TREATMENT OF GROWTH DISORDERS
  申请人：Pfizer Health AB

  公开号：EP1667671A1

  公开（公告）日：2006-06-14
• Enhanced method of treatment of growth disorders
  申请人：Cutfield Stephen Wayne

  公开号：US20070037861A1

  公开（公告）日：2007-02-15

  The application relates to the treatment of conditions and diseases for which growth hormone is a desirable method of treatment, using free fatty acid regulators in combination with growth hormone. In particular, the present invention discloses an enhanced method of treatment of growth disorders as well as methods to prevent and/or reduce adverse consequences of growth hormone treatment.